Metabolic Imaging Using Hyperpolarization for Assessment of Premalignancy.

Area of Science:

• Biomedical Imaging
• Metabolic Imaging
• Oncology

Background:

• Noninvasive surrogate markers are needed for early detection of premalignant lesions across various tumor types.
• Current diagnostic methods often lack the sensitivity to detect subtle metabolic changes indicative of early neoplastic transformation.
• Pancreatic cancer diagnosis remains challenging, necessitating novel approaches for identifying precursor lesions.

Purpose of the Study:

• To describe the methodology and technical details of in vivo ¹³C pyruvate metabolic imaging protocols.
• To identify and understand metabolic alterations associated with premalignant lesions.
• To establish a proof of concept for the high sensitivity of this imaging modality in detecting pancreatic premalignant lesions.

Main Methods:

• Utilized in vivo ¹³C pyruvate injection followed by magnetic resonance imaging (MRI).
• Detailed the specific protocols for data acquisition and analysis in metabolic imaging experiments.
• Focused on quantifying metabolic flux and identifying characteristic metabolic signatures.

Main Results:

• Demonstrated the feasibility of in vivo ¹³C pyruvate metabolic imaging.
• Identified specific metabolic changes indicative of premalignant states.
• Provided proof of concept for the high sensitivity of the technique.

Conclusions:

• In vivo ¹³C pyruvate metabolic imaging shows promise as a noninvasive tool for detecting premalignant lesions.
• This metabolic imaging approach can identify key metabolic alterations in early neoplastic disease.
• Further validation is warranted for clinical application in early cancer detection, particularly for pancreatic cancer.